News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–36
Matches
150
Sources here
18
Companies here
6
Search results Stored financial headlines

Active search

150 matching headlines

Ticker or company: CIGMain company stories
Clear
Latest

MarketBeat Earnings

KBC Group NV Buys 22,978 Shares of Cigna Group $CI

KBC Group NV increased its stake in Cigna Group (NYSE:CI) by 6.4% in the second quarter, acquiring an additional 22,978 shares, bringing their total ownership to 380,034 shares valued at over $104 million. Other institutional investors also adjusted their positions in Cigna, with hedge funds and institutional investors collectively owning 86.99% of the company's stock. Cigna reported strong …

Cigna Group $CI Stock Position Trimmed by Fifth Third Bancorp

Fifth Third Bancorp reduced its stake in Cigna Group (NYSE:CI) by 5.5% in Q2, selling 4,197 shares but still holding 72,463 shares valued at approximately $20 million. Despite this trim, institutional investors collectively own 86.99% of Cigna's stock. The health services provider recently beat …

CI main company
Sharemaestro market context Trend signal active 52 weeks -5.1% CI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Massachusetts Financial Services Co. MA Cuts Stock Position in Cigna Group $CI

Massachusetts Financial Services Co. MA significantly reduced its stake in Cigna Group (NYSE:CI) by 9.9% in the second quarter, selling 1.15 million shares but still holding a substantial position valued at $2.90 billion. Despite this reduction, Cigna maintains a "Moderate Buy" consensus rating from …

CI main company
Sharemaestro market context Trend signal active 52 weeks -5.1% CI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

VALLEY WEALTH MANAGERS, INC.'s The Cigna Group(CI) Holding History

VALLEY WEALTH MANAGERS, INC. holds 1,227.00 shares of The Cigna Group (CI) valued at $338,270.00 as of June 30, 2026, representing 0.02% of their portfolio. The firm has made 14 purchases and 19 sales of CI since 2018Q2, with an estimated gain of $7.00 …

CI main company
Sharemaestro market context Trend signal active 52 weeks -5.1% CI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Precigen (NASDAQ:PGEN) Trading Down 5.5% - What's Next?

Precigen (NASDAQ:PGEN) saw its shares drop by 5.5% despite reporting stronger-than-expected quarterly results, with EPS of $0.05 against an estimated loss of $0.01, and revenue soaring by 6,322.7% year-over-year to $54.98 million. The biotechnology company maintains a "Moderate Buy" consensus rating with an average …

PGEN main company
Sharemaestro market context Trend signal active 52 weeks +45.9% PGEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cigna Group stock outperforms competitors on strong trading day

Cigna Group (CI) shares rose 1.64% to $282.56, outperforming the broader market on a day when the S&P 500 and Dow Jones Industrial Average both fell. This marks the third consecutive day of gains for Cigna Group's stock.

CI main company
Sharemaestro market context Trend signal active 52 weeks -5.1% CI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Comp En De Mn Cemig ADS Q2 Earnings Call Highlights

Key Points Interested in Comp En De Mn Cemig ADS? Here are five stocks we like better. Cemig reported solid second-quarter results: recurring EBITDA rose 9.3% year over year to BRL 2.5 billion, while recurring net income increased 15.6%. The company is maintaining its …

CIG main company
Sharemaestro market context Price below Trend Line 52 weeks +7.0% CIG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

How Cigna’s Dividend Hike And Jefferies’ Downgrade At Cigna Group (CI) Has Changed Its Investment Story

Cigna Group recently declared a US$1.56 per share cash dividend with an ex-dividend date of September 8, 2026, while Jefferies downgraded its rating to 'hold' due to anticipated 2027 earnings headwinds. This situation highlights a tension between management's commitment to returning capital to shareholders …

CI main company
Sharemaestro market context Trend signal active 52 weeks -5.1% CI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Companhia Energética de Minas Gerais - CEMIG reports Q2 results

* Companhia Energética de Minas Gerais - CEMIG press release [https://ri.cemig.com.br/docs/Press-release-Cemig-2026-06-30-7pTb6qGD.pdf] (CIG [https://seekingalpha.com/symbol/CIG]): Q2 Revenue of R$11.16B (+3.4% Y/Y). * Consolidated EBITDA grew 8.8% YoY in 2Q26 and totaled R$2.24 billion, while Adjusted EBITDA was R$2.47 billion, up 9.3% from 2Q25. * Cemig reported …

CIG main company
Sharemaestro market context Price below Trend Line 52 weeks +7.0% CIG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cigna Group declares Q3 2026 distribution of R$ 0.22 per unit, payable Sept. 29

The Cigna Group has announced a Q3 2026 cash distribution of R$ 0.22 per unit (ISIN BRC1ICBDR000). Shares will trade with entitlement through September 3, 2026, with the payment scheduled for September 29, 2026. This news brief was generated by Public Technologies using AI …

CI main company
Sharemaestro market context Trend signal active 52 weeks -5.1% CI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Handelsbanken Fonder AB Buys 8,960 Shares of Cigna Group $CI

Handelsbanken Fonder AB increased its stake in Cigna Group (NYSE:CI) by 12.1% in the second quarter, acquiring an additional 8,960 shares, bringing its total to 82,825 shares valued at $22.83 million. Other institutional investors also adjusted their positions in Cigna. The article also details …

CI main company
Sharemaestro market context Trend signal active 52 weeks -5.1% CI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cigna Group (CI) Reports Fresh Earnings, Is The 19% Undervaluation Story Still Compelling?

Cigna Group (CI) recently released its second-quarter and first-half earnings, with its stock currently trading at $277.41, showing an 8.9% decline over the last 30 days despite a 47.94% 5-year return. Analysts view the stock as 18.6% undervalued, with a fair value of $340.92, …

CI main company
Sharemaestro market context Trend signal active 52 weeks -5.1% CI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Precigen (PGEN) Q2 2026 Earnings Call Transcript

Precigen (PGEN) reported its first-ever quarterly net profit in Q2 2026, driven by significant revenue growth for its lead therapy, PAPZIMEOS. The company saw a 145.8% increase in net revenue to $53.1 million, with high gross margins and broad payer coverage. Precigen anticipates continued …

PGEN main company
Sharemaestro market context Trend signal active 52 weeks +45.9% PGEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Companhia Energética de Minas Gerais - CEMIG Q2 Earnings Preview

* Companhia Energética de Minas Gerais - CEMIG (CIG [https://seekingalpha.com/symbol/CIG]) is scheduled to announce Q2 earnings results on Thursday, August 13th, after market close. * The consensus EPS estimate is $0.05, [https://seekingalpha.com/symbol/CIG/earnings/estimates] and the consensus revenue estimate is $1.74B MORE ON COMPANHIA ENERGÉTICA DE …

CIG main company
Sharemaestro market context Price below Trend Line 52 weeks +7.0% CIG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cigna Group stock underperforms Tuesday when compared to competitors

Cigna Group (CI) stock fell by 1.63% on Tuesday, closing at $273.87, underperforming against a general market decline where the S&P 500 Index and Dow Jones Industrial Average also saw losses. This marked the second consecutive day of losses for Cigna Group's stock.

CI main company
Sharemaestro market context Trend signal active 52 weeks -5.1% CI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Are Wall Street Analysts Bullish on Cigna Group Stock?

Doctor stacking healthcare medical insurance icons by Dilok via Adobe Stock Headquartered in Bloomfield, Connecticut, The Cigna Group (CI) is a global health company focused on improving health and vitality. Through Cigna Healthcare and Evernorth Health Services, it provides healthcare and related services to …

CI main company
Sharemaestro market context Trend signal active 52 weeks -5.1% CI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cigna Group (NYSE:CI) Receives Average Rating of "Moderate Buy" from Analysts

Cigna Group (NYSE:CI) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $339.45. The company recently reported strong quarterly results, exceeding EPS expectations and seeing a 6.7% revenue increase. Cigna has also reaffirmed its fiscal 2026 EPS …

CI main company
Sharemaestro market context Trend signal active 52 weeks -5.1% CI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cigna targets mid-market employers with Northern California appointment

Cigna Healthcare has appointed Luke Cirkovic as general manager for its Northern California market, focusing on employers with up to 2,999 employees. This move aligns with Cigna's strategic shift to prioritize its US employer business, following the sale of its Medicare Advantage business and …

CI main company
Sharemaestro market context Trend signal active 52 weeks -5.1% CI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cigna Group $CI Holdings Lifted by NewEdge Advisors LLC

NewEdge Advisors LLC increased its holdings in Cigna Group (NYSE:CI) by 47.8% in the first quarter, bringing its stake to 34,277 shares valued at $9.14 million. Cigna reported strong quarterly earnings of $7.78 per share, exceeding analyst expectations, and declared a quarterly dividend of …

CI main company
Sharemaestro market context Trend signal active 52 weeks -5.1% CI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cigna (CI) Stock Looks Undervalued As It Raises Full Year Outlook

Cigna (CI) stock appears undervalued despite a 46.9% return over five years and a recently raised full-year outlook. The company's P/E ratio of 11.6x is significantly lower than the Healthcare industry average of 24.9x and a peer group average of 32.1x, suggesting investors are …

CI main company
Sharemaestro market context Trend signal active 52 weeks -5.1% CI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cigna Group | 4: Statement of changes in beneficial ownership of securities-Officer Cordani David

This article provides a link to a "Statement of changes in beneficial ownership of securities" (Form 4) filing for Cigna Group. The filing pertains to officer David Cordani. Without further content, the specific details of the changes in ownership are not available.

CI main company
Sharemaestro market context Trend signal active 52 weeks -5.1% CI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cigna (CI) Stock Still Looks Cheap Following Raised 2026 Outlook

Cigna (CI) stock appears undervalued despite a 47.1% return over the past five years and recent strong earnings, including a raised 2026 outlook. The company trades at a P/E of 11.6x, significantly below the healthcare industry average of 25.3x, suggesting it remains inexpensive. While …

C1IC34 main company CI main company CIGN main company
Sharemaestro market context Trend signal ended 52 weeks -14.2% · Next-week setup negative 39.0% C1IC34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cigna Group (CI) Reports Q2 Earnings And Buybacks, Is It Trading At A Discount?

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Q2 earnings and buybacks put Cigna Group in focus Cigna Group (CI) is back …

C1IC34 main company CI main company CIGN main company
Sharemaestro market context Trend signal ended 52 weeks -14.2% · Next-week setup negative 39.0% C1IC34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Precigen (PGEN) Insider Rutul Shah Sells 32,739 Shares

Precigen (PGEN) insider Rutul Shah sold 32,739 shares of the company on August 6, 2026, totaling approximately $224,589. This transaction is part of a larger pattern where insiders have sold significantly more shares than they purchased over the past year. Despite the stock trading …

PGEN main company
Sharemaestro market context Trend signal active 52 weeks +45.9% PGEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

COO sale: Precigen (PGEN) insider trades 32,739 shares via plan

Precigen's Chief Operating Officer, Rutul R Shah, sold 32,739 shares of common stock at $6.86 per share on August 6, 2026, through a Rule 10b5-1 trading plan. Following this transaction, Shah directly holds 465,012 shares. The sale amounted to approximately $225,000, and the filing …

PGEN main company
Sharemaestro market context Trend signal active 52 weeks +45.9% PGEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cigna Group (NYSE: CI) EVP sells 19,436 shares after option exercise

Cigna Group's EVP, Nicole S. Jones, exercised 15,346 employee stock options and subsequently sold 19,436 common shares on August 4-5, 2026. These transactions, valued at approximately $5.37 million, were conducted under a pre-adopted Rule 10b5-1 trading plan. After the sales, Jones retains 28,557 direct …

CI main company
Sharemaestro market context Trend signal active 52 weeks -5.1% CI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pacer Advisors Inc. Sells 17,053 Shares of Cigna Group $CI

Pacer Advisors Inc. significantly reduced its stake in Cigna Group (NYSE:CI) during the first quarter, selling 17,053 shares, which represents a 56.4% decrease. Despite this, institutional investors collectively own a substantial 86.99% of Cigna's stock, and Wall Street analysts generally maintain a "Moderate Buy" …

CI main company
Sharemaestro market context Trend signal active 52 weeks -5.1% CI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Results: Precigen, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

The article discusses how Precigen, Inc. exceeded expectations, leading analysts to update their financial estimates for the company. This suggests a positive outlook for Precigen's future performance based on recent results.

PGEN main company
Sharemaestro market context Trend signal active 52 weeks +45.9% PGEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Insider Selling: Cigna Group (NYSE:CI) Insider Sells $5,369,583.72 in Stock

Cigna Group insider Nicole Jones sold 19,436 shares of the company's stock for approximately $5.37 million, reducing her direct ownership by 41.63%. This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan. Despite the insider selling, Cigna's shares rose, and the company reported …

CI main company
Sharemaestro market context Trend signal active 52 weeks -5.1% CI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Why Cigna Group (CI) Is Down 9.0% After Strong Q2 Results Meet PBM and Regulatory Jitters

Cigna Group (CI) reported strong Q2 2026 results with increased revenue and net income, alongside continued share repurchases. Despite this, the stock dropped 9.0% due to heightened regulatory scrutiny over its pharmacy benefit management (PBM) operations and ongoing business portfolio review. Analysts have expressed …

CI main company
Sharemaestro market context Trend signal active 52 weeks -5.1% CI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cigna Wins Dismissal Of Pa. In-Network Pharmacy Suit

A Pennsylvania federal judge dismissed a lawsuit against Cigna, Evernorth, and Express Scripts. The suit was brought by pharmacy customers who claimed injury because their community pharmacy was designated as out-of-network. The article, authored by Kellie Mejdrich, was published on August 6, 2026, at …

CI main company
Sharemaestro market context Trend signal active 52 weeks -5.1% CI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Precigen (PGEN) Is Up 16.3% After Papsimios-Fueled Return To Profitability And Broad Payer Coverage

Precigen (PGEN) reported a significant return to profitability in Q2 2026, driven by strong revenue and net income largely attributed to the rapid uptake of Papsimios. The company's profitability and broad payer coverage, along with seven-year FDA market exclusivity for Papsimios, strengthen its investment …

PGEN main company
Sharemaestro market context Trend signal active 52 weeks +45.9% PGEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context